Last updated on November 2017

Levemir ®, Lantus®, Humulin N®, Novolin N®, Basaglar®, or other long- acting insulin


Brief description of study

Levemir ®, Lantus®, Humulin N®, Novolin N®, Basaglar®, or other long- acting insulin

Detailed Study Description

Type 2 Diabetes? Currently using Insulin? Such as Levemir ®, Lantus®, Humulin N®, Novolin N®, Basaglar®, or other long- acting insulin

You may be eligible to participate in a 58 week Research Study if you are:

  • Diagnosed with Type 2 Diabetes
  • Currently using insulin
  • Age 18 or older

ClinicalTrials.gov Identifier: NCT03078478

Clinical Study Identifier: TX9843

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Christina Ludwick

Virginia Research Center
Midlothian, VA USA
  Connect »